$27M sweet spot round size
Most of their 34 investments are in rounds between $17M and $52M
2003
Zura Bio Limited raised $80M on April 27, 2023
Investors: Suvretta Capital Management LLC and Great Point Partners
Immunic Therapeutics raised $60M on October 10, 2022
Investors: Logos Global Management, LP, RTW Investments, LP, The Invus Group, Commodore Capital, LP, Parkman Healthcare Partners LLC, Vivo Capital and Great Point Partners
iXCells Biotechnologies raised undisclosed on September 29, 2022
Investors: Great Point Partners
Ventyx Biosciences raised $177M on September 19, 2022
Investors: Walleye Capital, Logos Global Management, LP, CaaS Capital Management, Woodline Partners LP, Vivo Capital, Redmile Group, Driehaus Capital Management LLC and Great Point Partners
Heron Therapeutics, Inc. raised $77M on August 9, 2022
Investors: Great Point Partners
Undisclosed raised undisclosed on July 22, 2022
Investors: Great Point Partners
JPA Health Communications raised undisclosed on May 4, 2022
Investors: Great Point Partners
Velentium raised undisclosed on September 30, 2021
Investors: Great Point Partners
BioAtla, Inc. raised $75M on September 29, 2021
Investors: Ikarian Capital LLC, Monashee Investment Management LLC, Hudson Bay Capital Management LP, Soleus Capital Management, L.P., Pappas Capital and Great Point Partners
Magenta Therapeutics raised $86M on May 12, 2021
Investors: TCG X and Great Point Partners